{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T03:06:19Z","timestamp":1782529579031,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Beijing Municipal Administration of Hospitals Incubating Program","award":["PX2020034"],"award-info":[{"award-number":["PX2020034"]}]},{"name":"Xuanwu Hospital Science Program for Fostering Young Scholars","award":["QNPY2020014"],"award-info":[{"award-number":["QNPY2020014"]}]},{"name":"Capital Medical University Scientific Research Cultivation Fund","award":["PYZ21033"],"award-info":[{"award-number":["PYZ21033"]}]},{"name":"The Pilot Project for Public Welfare Development and Reform of Beijing-affiliated Medical Research Institutes-Research on Intelligent Management and Innovative Model of Chronic Diseases in Elderly","award":["11000022T000000461062"],"award-info":[{"award-number":["11000022T000000461062"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-022-01861-z","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T07:03:46Z","timestamp":1657695826000},"page":"2275-2282","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Chinese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease have lower serum osteocalcin levels compared to individuals with type 2 diabetes mellitus and no liver disease: a single-center cross-sectional study"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0129-519X","authenticated-orcid":false,"given":"J.","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Xiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,13]]},"reference":[{"key":"1861_CR1","doi-asserted-by":"crossref","unstructured":"Lee CH, Lui DT (2022) Non-alcoholic fatty liver disease and type\u20092 diabetes: an update. J Diabetes Investig 13:930\u2013940","DOI":"10.1111\/jdi.13756"},{"issue":"21","key":"1861_CR2","first-page":"01280","volume":"S1542\u20133565","author":"MH Le","year":"2021","unstructured":"Le MH, Yeo YH, Li X et al (2021) 2019 global NAFLD prevalence: a systematic review and meta-analysis. Clin Gastroenterol Hepatol S1542\u20133565(21):01280\u201301285","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1861_CR3","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1002\/hep.30702","volume":"70","author":"F Zhou","year":"2019","unstructured":"Zhou F, Zhou J, Wang W et al (2019) Unexpected rapid increase in the burden of NAFLD in China From 2008 to 2018: a systematic review and meta-analysis. Hepatology 70:1119\u20131133","journal-title":"Hepatology"},{"key":"1861_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D et al (2016) Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64:73\u201384","journal-title":"Hepatology"},{"key":"1861_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2021.111491","volume":"93","author":"KJP Schwenger","year":"2022","unstructured":"Schwenger KJP, Kiu A, AlAli M et al (2022) Comparison of bioelectrical impedance analysis, mass index, and waist circumference in assessing risk for non-alcoholic steatohepatitis. Nutrition 93:111491","journal-title":"Nutrition"},{"key":"1861_CR6","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1007\/s40618-022-01792-9","volume":"45","author":"S Ciardullo","year":"2022","unstructured":"Ciardullo S, Bianconi E, Cannistraci R et al (2022) Peripheral artery disease and all-cause and cardiovascular mortality in patients with NAFLD. J Endocrinol Invest 45:1547\u20131553","journal-title":"J Endocrinol Invest"},{"key":"1861_CR7","doi-asserted-by":"publisher","first-page":"329","DOI":"10.14218\/JCTH.2021.00178","volume":"10","author":"E Kaya","year":"2022","unstructured":"Kaya E, Yilmaz Y (2022) Metabolic-associated fatty liver disease (MAFLD): a multi-systemic disease beyond the liver. J Clin Transl Hepatol 10:329\u2013338","journal-title":"J Clin Transl Hepatol"},{"key":"1861_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.599339","volume":"12","author":"HJ Lee","year":"2021","unstructured":"Lee HJ, Lee DC, Kim CO (2021) Association between 10-year fracture probability and nonalcoholic fatty liver disease with or without sarcopenia in Korean men: a nationwide population-based cross-sectional study. Front Endocrinol (Lausanne) 12:599339","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1861_CR9","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3389\/fendo.2018.00408","volume":"9","author":"Y Wang","year":"2018","unstructured":"Wang Y, Wen G, Zhou R et al (2018) Association of nonalcoholic fatty liver disease with osteoporotic fractures: a cross-sectional retrospective study of Chinese individuals. Front Endocrinol (Lausanne) 9:408","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1861_CR10","first-page":"926","volume":"10","author":"N Wang","year":"2019","unstructured":"Wang N, Wang Y, Chen X et al (2019) Bone turnover markers and probable advanced nonalcoholic fatty liver disease in middle-aged and elderly men and postmenopausal women with type 2 diabetes. BMJ Open Diabetes Res Care 10:926","journal-title":"BMJ Open Diabetes Res Care"},{"key":"1861_CR11","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.diabet.2018.10.001","volume":"45","author":"A Mantovani","year":"2019","unstructured":"Mantovani A, Sani E, Fassio A et al (2019) Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes. Diabetes Metab 45:347\u2013355","journal-title":"Diabetes Metab"},{"key":"1861_CR12","first-page":"1256","volume":"30","author":"R D\u00edez Rodr\u00edguez","year":"2014","unstructured":"D\u00edez Rodr\u00edguez R, Ballesteros Pomar MD, Calleja Fern\u00e1ndez A et al (2014) Vitamin D levels and bone turnover markers are not related to non-alcoholic fatty liver disease in severely obese patients. Nutr Hosp 30:1256\u20131262","journal-title":"Nutr Hosp"},{"key":"1861_CR13","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000369789","volume":"91","author":"DH Sinn","year":"2015","unstructured":"Sinn DH, Gwak GY, Rhee SY et al (2015) Association between serum osteocalcin levels and non-alcoholic fatty liver disease in women. Digestion 91:150\u2013157","journal-title":"Digestion"},{"key":"1861_CR14","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s12020-016-0926-5","volume":"53","author":"J Du","year":"2016","unstructured":"Du J, Zhang M, Lu J et al (2016) Osteocalcin improves nonalcoholic fatty liver disease in mice through activation of Nrf2 and inhibition of JNK. Endocrine 53:701\u2013709","journal-title":"Endocrine"},{"key":"1861_CR15","doi-asserted-by":"publisher","first-page":"9178616","DOI":"10.1155\/2021\/9178616","volume":"2021","author":"M Zhang","year":"2021","unstructured":"Zhang M, Nie X, Yuan Y et al (2021) Osteocalcin alleviates nonalcoholic fatty liver disease in mice through GPRC6A. Int J Endocrinol 2021:9178616","journal-title":"Int J Endocrinol"},{"key":"1861_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/197519","volume":"2013","author":"AA Alfadda","year":"2013","unstructured":"Alfadda AA, Masood A, Shaik SA et al (2013) Association between osteocalcin, metabolic syndrome, and cardiovascular risk factors: role of total and undercarboxylated osteocalcin in patients with type 2 diabetes. Int J Endocrinol 2013:197519","journal-title":"Int J Endocrinol"},{"key":"1861_CR17","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s10654-015-0058-x","volume":"30","author":"SK Kunutsor","year":"2015","unstructured":"Kunutsor SK, Apekey TA, Laukkanen JA (2015) Association of serum total osteocalcin with type 2 diabetes and intermediate metabolic phenotypes: systematic review and meta-analysis of observational evidence. Eur J Epidemiol 30:599\u2013614","journal-title":"Eur J Epidemiol"},{"key":"1861_CR18","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1038\/aps.2015.81","volume":"36","author":"YQ Luo","year":"2015","unstructured":"Luo YQ, Ma XJ, Hao YP et al (2015) Inverse relationship between serum osteocalcin levels and nonalcoholic fatty liver disease in postmenopausal Chinese women with normal blood glucose levels. Acta Pharmacol Sin 36:1497\u20131502","journal-title":"Acta Pharmacol Sin"},{"key":"1861_CR19","doi-asserted-by":"crossref","unstructured":"(2019) 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019. Diabetes Care 42:S13\u2013S28","DOI":"10.2337\/dc19-S002"},{"key":"1861_CR20","first-page":"163","volume":"18","author":"F Jian-gao","year":"2010","unstructured":"Jian-gao F (2010) Guidelines for management of nonalcoholic fatty liver disease: an updated and revised edition. Zhonghua Gan Zang Bing Za Zhi 18:163\u2013166","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"1861_CR21","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3748\/wjg.v28.i3.310","volume":"28","author":"L Chrysavgis","year":"2022","unstructured":"Chrysavgis L, Giannakodimos I, Diamantopoulou P et al (2022) Non-alcoholic fatty liver disease and hepatocellular carcinoma: clinical challenges of an intriguing link. World J Gastroenterol 28:310\u2013331","journal-title":"World J Gastroenterol"},{"key":"1861_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4254\/wjh.v14.i1.119","volume":"14","author":"I Tzanaki","year":"2022","unstructured":"Tzanaki I, Agouridis AP, Kostapanos MS (2022) Is there a role of lipid-lowering therapies in the management of fatty liver disease? World J Hepatol 14:119\u2013139","journal-title":"World J Hepatol"},{"key":"1861_CR23","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.4239\/wjd.v12.i9.1479","volume":"12","author":"R Khandelwal","year":"2021","unstructured":"Khandelwal R, Dassanayake AS, Conjeevaram HS et al (2021) Non-alcoholic fatty liver disease in diabetes: when to refer to the hepatologist? World J Diabetes 12:1479\u20131493","journal-title":"World J Diabetes"},{"key":"1861_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrendo.2017.173","volume":"14","author":"G Targher","year":"2018","unstructured":"Targher G, Lonardo A, Byrne CD (2018) Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus. Nat Rev Endocrinol 14:99\u2013114","journal-title":"Nat Rev Endocrinol"},{"key":"1861_CR25","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.12669\/pjms.37.5.4211","volume":"37","author":"S Kanwal","year":"2021","unstructured":"Kanwal S, Ghaffar T, Aamir AH et al (2021) Frequency of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus and its associated risk factors. Pak J Med Sci 37:1335\u20131341","journal-title":"Pak J Med Sci"},{"key":"1861_CR26","doi-asserted-by":"publisher","first-page":"96","DOI":"10.5414\/CN110394","volume":"96","author":"B Karadeniz","year":"2021","unstructured":"Karadeniz B, Gur C, Cakir D et al (2021) The relationship between glycemic control and osteocalcin, type 1 collagen C-terminal telopeptide, bone-specific alkaline phosphatase and the effects of anti-diabetic regimens on circulating markers of bone turnover in newly diagnosed diabetic patients: bone health in diabetics. Clin Nephrol 96:96\u2013104","journal-title":"Clin Nephrol"},{"key":"1861_CR27","volume":"12","author":"WJ Lee","year":"2021","unstructured":"Lee WJ, Lin SY, Li WC et al (2021) Optimal threshold of homeostasis model assessment of insulin resistance to identify metabolic syndrome in a Chinese population aged 45 years or younger. J Clin Med 12:746747","journal-title":"J Clin Med"},{"key":"1861_CR28","doi-asserted-by":"publisher","first-page":"591","DOI":"10.29271\/jcpsp.2022.05.591","volume":"32","author":"E Cigri","year":"2022","unstructured":"Cigri E, Inan FC, Er E et al (2022) The relationship between lipid profile and non-alcoholic fatty liver disease in children and adolescents with obesity. J Coll Physicians Surg Pak 32:591\u2013595","journal-title":"J Coll Physicians Surg Pak"},{"key":"1861_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108027","volume":"160","author":"X Han","year":"2020","unstructured":"Han X, Xu P, Zhou J et al (2020) Fasting C-peptide is a significant indicator of nonalcoholic fatty liver disease in obese children. Diabetes Res Clin Pract 160:108027","journal-title":"Diabetes Res Clin Pract"},{"key":"1861_CR30","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s00592-019-01374-x","volume":"56","author":"A Mansour","year":"2019","unstructured":"Mansour A, Mohajeri-Tehrani MR, Samadi M et al (2019) Risk factors for non-alcoholic fatty liver disease-associated hepatic fibrosis in type 2 diabetes patients. Acta Diabetol 56:1199\u20131207","journal-title":"Acta Diabetol"},{"key":"1861_CR31","volume":"12","author":"C Zhang","year":"2021","unstructured":"Zhang C, Liu S, Yang M (2021) Hepatocellular carcinoma and obesity, type 2 diabetes mellitus, cardiovascular disease: causing factors, molecular links, and treatment options. Biomedicines 12:808526","journal-title":"Biomedicines"},{"key":"1861_CR32","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.soard.2014.06.015","volume":"11","author":"M Subichin","year":"2015","unstructured":"Subichin M, Clanton J, Makuszewski M et al (2015) Liver disease in the morbidly obese: a review of 1000 consecutive patients undergoing weight loss surgery. Surg Obes Relat Dis 11:137\u2013141","journal-title":"Surg Obes Relat Dis"},{"key":"1861_CR33","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1002\/hep4.1766","volume":"5","author":"CC Cohen","year":"2021","unstructured":"Cohen CC, Castillo-Leon E, Farris AB et al (2021) PRO-C3, a serological marker of fibrosis, during childhood and correlations with fibrosis in pediatric NAFLD. Hepatol Commun 5:1860\u20131872","journal-title":"Hepatol Commun"},{"key":"1861_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bcp.2017.02.001","volume":"132","author":"A Mizokami","year":"2017","unstructured":"Mizokami A, Kawakubo-Yasukochi T, Hirata M (2017) Osteocalcin and its endocrine functions. Biochem Pharmacol 132:1\u20138","journal-title":"Biochem Pharmacol"},{"key":"1861_CR35","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.bone.2011.04.017","volume":"50","author":"M Ferron","year":"2012","unstructured":"Ferron M, McKee MD, Levine RL et al (2012) Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. Bone 50:568\u2013575","journal-title":"Bone"},{"key":"1861_CR36","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.1210\/en.2014-1430","volume":"155","author":"AA Gupte","year":"2014","unstructured":"Gupte AA, Sabek OM, Fraga D et al (2014) Osteocalcin protects against nonalcoholic steatohepatitis in a mouse model of metabolic syndrome. Endocrinology 155:4697\u20134705","journal-title":"Endocrinology"},{"key":"1861_CR37","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1210\/en.2012-2144","volume":"154","author":"B Zhou","year":"2013","unstructured":"Zhou B, Li H, Xu L et al (2013) Osteocalcin reverses endoplasmic reticulum stress and improves impaired insulin sensitivity secondary to diet-induced obesity through nuclear factor-\u03baB signaling pathway. Endocrinology 154:1055\u20131068","journal-title":"Endocrinology"},{"key":"1861_CR38","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/MPG.0000000000001768","volume":"66","author":"S Amin","year":"2018","unstructured":"Amin S, El Amrousy D, Elrifaey S et al (2018) Serum osteocalcin levels in children with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 66:117\u2013121","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1861_CR39","doi-asserted-by":"publisher","first-page":"631","DOI":"10.3109\/00365513.2011.604427","volume":"71","author":"Y Yilmaz","year":"2011","unstructured":"Yilmaz Y, Kurt R, Eren F et al (2011) Serum osteocalcin levels in patients with nonalcoholic fatty liver disease: association with ballooning degeneration. Scand J Clin Lab Invest 71:631\u2013636","journal-title":"Scand J Clin Lab Invest"},{"key":"1861_CR40","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1007\/s11695-016-2123-2","volume":"26","author":"M Luger","year":"2016","unstructured":"Luger M, Kruschitz R, Kienbacher C et al (2016) Prevalence of liver fibrosis and its association with non-invasive fibrosis and metabolic markers in morbidly obese patients with vitamin D deficiency. Obes Surg 26:2425\u20132432","journal-title":"Obes Surg"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-022-01861-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-022-01861-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-022-01861-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T21:06:12Z","timestamp":1668027972000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-022-01861-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,13]]},"references-count":40,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1861"],"URL":"https:\/\/doi.org\/10.1007\/s40618-022-01861-z","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,13]]},"assertion":[{"value":"5 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study involving human participants were in accordance with the ethical standards of the Xuanwu Hospital of Capital Medical University Ethics Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standard"}},{"value":"The study was conducted in accordance with the principles of the Declaration of Helsinki of 1975, as revised in 2008.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Informed consent was obtained from all patients for being included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The author certifies that they have obtained all appreciate patient consent forms. In the form, the patients have given their consent for their images and other clinical information to be reported in the journal.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of patient consent"}}]}}